drugset
drugset / Trial / NCT00240877

Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024)

NCT00240877 ↗

Phase 3 Completed 330 enrolled MedImmune LLC
RandomizedParallel-groupDouble-blindPrevention

Summary

To assess the safety of a vaccine in healthy adults prior to the release of the trivalent vaccine (FluMist).

Timeline

Start
2002-08
Primary completion
2003-08
Completion
2004-04

Drugs

EvaluationDrugModalityDoseRoute
Subject AV024 Vaccine 0.5 ml Intranasal

Indications

influenza